Cardiovascular risk management requires a combination of cardiovascular preventive pharmacotherapy and non-pharmacological interventions

Eur J Prev Cardiol. 2022 Sep 7;29(12):e312-e313. doi: 10.1093/eurjpc/zwac082.

Authors

Suneela Mehta^{1

2}, Jinfeng Zhao¹, Katrina Poppe¹, Andrew J Kerr^{1

3}, Sue Wells¹, Dan J Exeter¹, Vanessa Selak¹, Corina Grey^{1

4}, Rod Jackson¹

Affiliations

¹ Section of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand.
² Planning, Funding and Outcomes Team, Waitematā and Auckland District Health Boards, Auckland, New Zealand.
³ Cardiology Services, Middlemore Hospital, Auckland, New Zealand.
⁴ Strategy and Performance Improvement Teams, Auckland District Health Board, Auckland, New Zealand.

PMID: 35512449
DOI: 10.1093/eurjpc/zwac082

No abstract available

Publication types

Comment

MeSH terms

Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Cardiovascular System*
Heart Disease Risk Factors
Humans
Risk Factors